Press release
Global Omega 3 Prescription Drugs Market Projected to Surpass $2.61 Billion by 2029 with 10.3% Annual Growth
Omega 3 Prescription Drugs
The surging number of cardiovascular diseases (CVDs) is projected to bolster the upward trend of the omega-3 prescription drug market. Elevated levels of blood triglycerides, a fat-like substance, are associated with an elevated risk of cardiovascular issues, and omega-3 supplements play a vital role in regulating and decreasing these levels. As an illustration, the World Health Organization's (WHO) 2022 report discloses that CVDs persist as the leading cause of global deaths, accounting for nearly 20.5 million fatalities, which comprises almost a third of all deaths globally. This is a notable surge compared to the prior estimate of 121 million deaths related to CVDs. Therefore, the escalating prevalence of CVDs propels the expansion of the omega-3 prescription drug market.
Get Your Omega 3 Prescription Drugs Market Report Here:
https://www.thebusinessresearchcompany.com/report/omega-3-prescription-drugs-global-market-report
What is the future CAGR of the omega 3 prescription drugs market, and how will it impact industry expansion?
In recent times, the market size of omega 3 prescription drugs has seen significant growth. The market is projected to expand from a worth of $1.61 billion in 2024 to $1.76 billion in 2025, witnessing a compound annual growth rate (CAGR) of 9.5%. The growth observed in the historic period can be linked to increased health consciousness, clinical research findings, focus on cardiovascular health, doctors' recommendations, and management of chronic diseases.
The market size for omega 3 prescription drugs is anticipated to expand quickly in the forthcoming years, poised to reach $2.61 billion in 2029 with a compound annual growth rate (CAGR) of 10.3%. The anticipated growth over this forecast period is due to a number of factors such as increasing indications, shifting consumer preferences, custom healthcare solutions, individualized medicine, and growth in clinical evidence. The period under review is expected to witness trends such as tailored health solutions, broadened health conditions, creative formulations, the rise in health supplement appeal, and the growing popularity of health apps and wearables.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8091&type=smp
What trends are poised to drive the future success of the omega 3 prescription drugs market?
There has been an upward trend in the omega-3 prescription drug market due to novel product developments. Major participants in the omega-3 drug manufacturing sector are focusing on creating fresh innovations to solidify their market standing. For example, in October 2022, DSM was given approval by the European Commission to introduce their plant-based omega-3 products as fish and animal substitutes throughout Europe. DSM asserts that these products not only improve the nutritional value of plant-based foods, but also pave the way for the creation of animal-based fish products similar to existing fish products. This omega-3 supplement offers a way to boost the nutritional value of commodities without negatively impacting the marine ecosystem.
Which primary segments of the omega 3 prescription drugs market are driving growth and industry transformations?
The omega 3 prescription drugs market covered in this report is segmented -
1) By Drug Type: Vascepa, Lovaza, Other Type
2) By Application Type: Hypertriglyceridemia, Other Application Type
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
Subsegments:
1) By Vascepa: Pure EPA (Eicosapentaenoic Acid) Formulation, Indications For Cardiovascular Risk Reduction
2) By Lovaza: Combination Of EPA And DHA (Docosahexaenoic Acid), Indications For Hypertriglyceridemia Management
3) By Other Types: Epanova (Omega-3 Carboxylic Acids), Omega-3 Formulations In Clinical Trials, Other Prescription Omega-3 Products
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8091
Which geographical regions are pioneering growth in the omega 3 prescription drugs market?
North America was the largest region in the omega 3 prescription drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the omega 3 prescription drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Who are the influential players reshaping the omega 3 prescription drugs market landscape?
Major companies operating in the omega 3 prescription drugs market include Ionis Pharmaceuticals, Sarepta Therapeutics, Alnylam Pharmaceuticals, Wave Life Sciences, Dyno Therapeutics, BioNTech SE, Moderna Therapeutics, Silence Therapeutics, Arrowhead Pharmaceuticals, ProQR Therapeutics, Regulus Therapeutics, Stoke Therapeutics, Editas Medicine, Beam Therapeutics, Miragen Therapeutics, Biogen Inc., Pfizer Inc., GlaxoSmithKline plc, Arbutus Biopharma, Sanofi S.A., Benitec Biopharma, CRISPR Therapeutics, Dicerna Pharmaceuticals, Translate Bio, PepGen Inc., Sirnaomics Inc., Sterna Biologicals, Genevant Sciences, Genzyme Corporation.
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=8091&type=smp
What Is Covered In The Omega 3 Prescription Drugs Global Market Report?
•Market Size Forecast: Examine the omega 3 prescription drugs market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the omega 3 prescription drugs market for a structured understanding.
•Key Players Overview: Analyze major players in the omega 3 prescription drugs market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the omega 3 prescription drugs market.
•Segment Contributions: Evaluate how different segments drive overall growth in the omega 3 prescription drugs market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the omega 3 prescription drugs market.
•Industry Challenges: Identify potential risks and obstacles affecting the omega 3 prescription drugs market.
•Competitive Landscape: Review strategic developments in the omega 3 prescription drugs market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Omega 3 Prescription Drugs Market Projected to Surpass $2.61 Billion by 2029 with 10.3% Annual Growth here
News-ID: 3912126 • Views: …
More Releases from The Business Research Company
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Company Registration Service Market Through 2025?
The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth…
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025?
In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of…
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025?
The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in…
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025?
In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth…
More Releases for Therapeutics
Adrenomyeloneuropathy Market: Epidemiology, Therapies, Companies, DelveInsight | …
Adrenomyeloneuropathy emerging therapies are expected to boost the Adrenomyeloneuropathy Market in the upcoming years.
DelveInsight has launched a new report on "Adrenomyeloneuropathy - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Adrenomyeloneuropathy, historical and forecasted epidemiology as well as the Adrenomyeloneuropathy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Discover about the Adrenomyeloneuropathy market report @ https://www.delveinsight.com/report-store/adrenomyeloneuropathy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Some of the…
Pompe Disease Market: Epidemiology, Therapies, Companies, DelveInsight | Genzyme …
Pompe Disease emerging therapies, such as MYOZYME (alglucosidase alfa), LUMIZYME, AAV2/8-LSPhGAA, Avalglucosidase alfa, and others, are expected to boost the Pompe Disease Market in the upcoming years.
DelveInsight has launched a new report on "Pompe Disease - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Pompe Disease, historical and forecasted epidemiology as well as the Pompe Disease market trends in the United States, EU5 (Germany, Spain,…
Dark Genome Therapeutics Market Deep Research Report with Forecast to 2032 | myN …
The qualitative latest Research report (2025-2032) on the Dark Genome Therapeutics Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves.
Request a Sample Copy: https://www.coherentmarketresearch.com/samplepages/133611
Focused on growth…
Hodgkin's lymphoma Therapeutics Market Size Report 2032 | Affimed Therapeutics, …
DelveInsight's "Hodgkin's Lymphoma Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Hodgkin's Lymphoma, historical and forecasted epidemiology as well as the Hodgkin's Lymphoma market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United kingdom and Japan.
Discover Key Insights into the Hodgkin's lymphoma Market with DelveInsight's In-Depth Report @ Hodgkin's lymphoma Market Size- https://www.delveinsight.com/sample-request/hodgkins-lymphoma-hl-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Hodgkin's…
CRISPR Therapies Pipeline 2024 | Intellia Therapeutics, CRISPR therapeutics, Rep …
DelveInsight's, "CRISPR Therapies Pipeline Insight 2024" report provides comprehensive insights about 25+ CRISPR Therapies Companies and 30+ pipeline drugs in CRISPR Therapies pipeline landscape. It covers the CRISPR Therapies pipeline drug profiles, including clinical and nonclinical stage products. It also covers the CRISPR Therapies therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive CRISPR Therapies pipeline products in this space.
Key Takeaways from…
Digital Therapeutics Market, Digital Therapeutics Market Size, Digital Therapeut …
The global digital therapeutics market is expected to reach US$ 8,941.1 Mn by 2025 from US$ 1,993.2 Mn in 2017. The market is estimated to grow with a CAGR of 20.8% during the forecast period from 2018 to 2025.
North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significant…
